DKK, a Wnt pathway inhibitor, reversed the resistance of breast cancer cells to PTX, anti-apoptosis, and high expression of stem cell markers induced by HIF-2α overexpression, which confirms that HIF-2α induced stem cell phenotype conversion and resistance to PTX by activating the Wnt pathway. This evidence concerns the gene EPAS1 and breast carcinoma.